Navigation Links
New study reveals how to strike a balance between heart-healthy fats

Food that is good for health, especially the role of fats, had been debated for a long// time. The researchers from Penn State University had found out that the between the various kinds of fats that are heart healthy, it is not possible to have the healthy meal by banishing one kind of fat totally and taking only one particular kind of fats. The right combination of both can help achieve the best possible diet for reducing cholesterol and stay healthy.

Fatty foods that contain polyunsaturated fatty acids (PUFAs) are often given a preference over the fats of the variety mono-unsaturated fatty acids (MUFAs). Previously there were no clear recommendations of how much from each of these fat groups are good for health.

Researchers have compared the comparative role of both the dietary fats in their study for achieving optimum dietary benefits for lowering the risks of cardiovascular disease. They have taken two heart healthy oils such as sunflower oil that is rich in PUFA, and olive oil that is rich in MUFA.

The PUFA rich diet did reduce the total and LDL cholesterol levels in people, as expected. However, the dietary fat rich in MUFA surprisingly did not reduce cholesterol levels as was expected. Also the greater percentage of PUFA in the fats did not increase the risk factors for atherosclerosis.

Researchers feel only a balance of both of these together can be beneficial to good health, instead of adopting any one in our diet.

Reference: Journal of the American Dietetic Association, July 2005
'"/>




Page: 1

Related medicine news :

1. A new study surpasses Gene Therapy Hurdle
2. A question on study of Adult Stem Cell
3. Marijuana gateway theory strengthened by study of twins
4. Old theory of adaptation confirmed by new study
5. Gene study links endometriosis, infertility
6. Mutant sperm beat out healthy brethren in study
7. New study questions consumption of milk for bone growth
8. New study questions consumption of milk for bone growth
9. Going to GP may delay cancer diagnosis, says new study
10. Drug addiction can be genetical, says study
11. Autism epidemic is a myth- says a new study
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: